Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$33.69 USD
+5.05 (17.63%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $33.75 +0.06 (0.18%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Income Statements
Fiscal Year end for Surgery Partners, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,743 | 2,539 | 2,225 | 1,860 | 1,831 |
Cost Of Goods | 2,096 | 1,964 | 1,734 | 1,480 | 1,408 |
Gross Profit | 648 | 575 | 491 | 380 | 424 |
Selling & Adminstrative & Depr. & Amort Expenses | 348 | 255 | 212 | 218 | 208 |
Income After Depreciation & Amortization | 300 | 320 | 280 | 161 | 216 |
Non-Operating Income | 0 | 0 | 0 | 0 | -2 |
Interest Expense | 193 | 235 | 221 | 202 | 179 |
Pretax Income | 135 | 110 | 81 | -19 | 55 |
Income Taxes | 0 | 23 | 11 | -20 | 10 |
Minority Interest | 147 | 142 | 142 | 117 | 120 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 135 | 87 | 71 | 1 | 45 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -12 | -55 | -71 | -116 | -75 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 418 | 435 | 378 | 256 | 292 |
Depreciation & Amortization (Cash Flow) | 118 | 115 | 99 | 95 | 77 |
Income After Depreciation & Amortization | 300 | 320 | 280 | 161 | 216 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 125.61 | 91.95 | 72.43 | 48.78 | 48.28 |
Diluted EPS Before Non-Recurring Items | 0.86 | -0.04 | -0.25 | -1.49 | -1.10 |
Diluted Net EPS (GAAP) | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 |
Fiscal Year end for Surgery Partners, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 762.10 | 717.40 | 735.40 | 674.10 | 667.60 |
Cost Of Goods | 582.90 | 562.10 | 541.80 | 508.30 | 513.50 |
Gross Profit | 179.20 | 155.30 | 193.60 | 165.80 | 154.10 |
SG&A, R&D, and Dept/Amort Expenses | 103.20 | 84.70 | 101.80 | 90.20 | 61.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 76.00 | 70.60 | 91.80 | 75.60 | 92.40 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 51.50 | 47.30 | 48.70 | 49.80 | 47.70 |
Pretax Income | 33.30 | 28.70 | 52.70 | 32.80 | 49.90 |
Income Taxes | 4.90 | 4.40 | 6.00 | 3.10 | -7.80 |
Minority Interest | 43.90 | 36.70 | 47.70 | 34.60 | 38.80 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 28.40 | 24.30 | 46.70 | 29.70 | 57.70 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -15.50 | -12.40 | -1.00 | -4.90 | 18.90 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 126.13 | 125.97 | 125.77 | 125.75 | 127.37 |
Diluted EPS Before Non-Recurring Items | 0.10 | 0.06 | 0.40 | 0.15 | 0.25 |
Diluted Net EPS (GAAP) | -0.12 | -0.10 | 0.00 | -0.04 | 0.15 |